Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy

Código QR

Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy

William G North,1 Fuli Liu,1 Konstantin H Dragnev,1,2 Eugene Demidenko3 1Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA; 2Department of Medicine, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA; 3Department of Community...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	North WG, Liu F, Dragnev KH, Demidenko E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	small-cell lung cancer NMDA receptors inhibitors combination therapy Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/6c18d3a3e95a48b581858a80bfe82022
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment
por: North WG, et al.
Publicado: (2017)

A glutamate concentration‐biased allosteric modulator potentiates NMDA‐induced ion influx in neurons
por: Blaise M. Costa, et al.
Publicado: (2021)

<italic toggle="yes">N</italic>-Methyl-<sc>d</sc>-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection
por: Vivian V. Costa, et al.
Publicado: (2017)

N-Methyl-d-aspartate (NMDA) receptor antibody in relation to autism spectrum disorder (ASD): presence and association with symptom profile
por: Heba Hamed Elshahawi, et al.
Publicado: (2021)

<i>N</i>-Methyl-<span style="font-variant: small-caps">d</span>-aspartic Acid (NMDA) Receptor Is Involved in the Inhibitory Effect of Ketamine on Human Sperm Functions
por: Ying Chen, et al.
Publicado: (2021)

The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report
por: Nikolai A. Ognerubov, et al.
Publicado: (2021)

Cre-Activation in ErbB4-Positive Neurons of Floxed Grin1/NMDA Receptor Mice Is Not Associated With Major Behavioral Impairment
por: Anne S. Mallien, et al.
Publicado: (2021)

Analysis of the NMDA in Focal Cerebral Ischemia in Rats
por: Tirapelli,D. P. C, et al.
Publicado: (2012)

A Model for Predicting Cation Selectivity and Permeability in AMPA and NMDA Receptors Based on Receptor Subunit Composition
por: Sampath Kumar, et al.
Publicado: (2021)

Anti-NMDA-receptor encephalitis: an unusual treatable cause of chronic insomnia?
por: Wietse A. Wiels, et al.
Publicado: (2021)

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
por: Wen M, et al.
Publicado: (2018)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shijie Shang, et al.
Publicado: (2021)

Recidiva de teratoma ovárico tras encefalitis anti-NMDA y manejo de la fertilidad: caso clínico.
por: Gastañaga-Holguera,Teresa, et al.
Publicado: (2017)

A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity
por: Lee CS, et al.
Publicado: (2020)

Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly
por: María J Conde-Dusman, et al.
Publicado: (2021)

Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
por: Mateusz Kowalczyk, et al.
Publicado: (2021)

The Ki-67 Proliferation Index-Related Nomogram to Predict the Response of First-Line Tyrosine Kinase Inhibitors or Chemotherapy in Non-small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor-Mutant Status
por: Weiguo Gu, et al.
Publicado: (2021)

Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases
por: Ling-Ling Kong, et al.
Publicado: (2017)

Oligoprogression in Non-Small Cell Lung Cancer
por: Daijiro Harada, et al.
Publicado: (2021)

Early multidisciplinary intensive-care therapy can improve outcome of severe anti-NMDA-receptor encephalitis presenting with extreme delta brush
por: Schneider R., et al.
Publicado: (2019)

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
por: Nathaniel Wiest, et al.
Publicado: (2021)

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Guido Kroemer, et al.
Publicado: (2021)

Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
por: Svetlana V. Odintsova, et al.
Publicado: (2020)

Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer
por: Brazel D, et al.
Publicado: (2021)

Robust Expression of Functional NMDA Receptors in Human Induced Pluripotent Stem Cell-Derived Neuronal Cultures Using an Accelerated Protocol
por: Jacob B. Ruden, et al.
Publicado: (2021)

Blockade of Cellular Energy Metabolism through 6-Aminonicotinamide Reduces Proliferation of Non-Small Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress
por: Neha Kaushik, et al.
Publicado: (2021)

Coexistence of Anti-SOX1 and Anti-GABAB Receptor Antibodies with Autoimmune Encephalitis in Small Cell Lung Cancer: A Case Report
por: Qin W, et al.
Publicado: (2020)

Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer
por: Cristina Minnelli, et al.
Publicado: (2021)

Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
por: Galina B. Statsenko, et al.
Publicado: (2020)

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy
por: Gan J, et al.
Publicado: (2021)

Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro
por: Yanguo Liu, et al.
Publicado: (2021)

Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer
por: Wang S, et al.
Publicado: (2021)

Astrocyte GluN2C NMDA receptors control basal synaptic strengths of hippocampal CA1 pyramidal neurons in the stratum radiatum
por: Peter H Chipman, et al.
Publicado: (2021)

Targeting RET-rearranged non-small-cell lung cancer: future prospects
por: Bronte G, et al.
Publicado: (2019)

Walnut Kernel administration to mothers during pregnancy and lactation improve learning of their pups. Changes in number of neurons and gene expression of NMDA receptor and BDNF in hippocampus in 80 days rat pups
por: Mahmoodian Zahra, et al.
Publicado: (2020)

Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
por: Wenxiao Jiang, et al.
Publicado: (2021)

Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
por: Denis I. Yudin, et al.
Publicado: (2021)

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study
por: Khan M, et al.
Publicado: (2021)

New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
por: Seetharamu N, et al.
Publicado: (2017)

Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report
por: Albina S. Zhabina, et al.
Publicado: (2021)